Renal Function in Primary Liver Transplant Recipients Receiving Neoral (Cyclosporine) Versus Prograf (Tacrolimus)
| Autor: | J Payne, Sunil K. Geevarghese, R. E. Richie, MacDonell Rc, J.K Wright, J H Helderman, D. H. Van Buren, William C. Chapman, C.W Pinson |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Graft Rejection
medicine.medical_specialty Time Factors Urology Renal function Kidney Tacrolimus Postoperative Complications Diabetes mellitus Azathioprine Diabetes Mellitus medicine Humans Prospective Studies Prospective cohort study Survival rate Analysis of Variance Transplantation business.industry Incidence Ciclosporin medicine.disease Liver Transplantation Surgery Survival Rate Creatinine Chemoprophylaxis Cyclosporine Prednisone Regression Analysis business Immunosuppressive Agents Follow-Up Studies medicine.drug |
| Zdroj: | Transplantation Proceedings. 30:1401-1402 |
| ISSN: | 0041-1345 |
| DOI: | 10.1016/s0041-1345(98)00289-9 |
| Popis: | Immunosuppressive efficacy of Neoral and Prograf following primary hepatic transplantation was comparable. Incidence of rejection episodes, infectious complications, hypertension, and postoperative diabetes mellitus was comparable. Although clinical use of both immunosuppressants was associated with early compromise in renal function, no progressive renal dysfunction was observed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect